Our goal is to improve the lives of others as much as we can. While our focus is grantmaking, what matters most to us is an organization’s potential for impact — not its tax status.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Kainomyx to support the development and production of new drugs to treat malaria and other parasitic diseases, such as cryptosporidiosis and toxoplasmosis.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in OliLux Biosciences to support the development of diagnostic and treatment monitoring tools for the detection and management of tuberculosis.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in VasoRX to support work work testing a new therapy for vascular diseases such as atherosclerosis and pulmonary arterial hypertension.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Binx to support work to incorporate Sherlock Biosciences's COVID-19 assay into Binx's point-of-care diagnostic platform.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Riboscience to support work to test a new drug candidate against COVID-19.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Icosavax to support the development of a new nanoparticle COVID-19 vaccine.